Neuroimmunology in multiple sclerosis
Original Articles
- 21 Downloads
Abstract
A review of latest immunological interpretations regarding the pathogenesis of Multiple the Sclerosis.
Data on a new immunoenzymatic method for the identification of blood lymphocyte populations are presented together with preliminary results relating to an immunogenetic correlation between primary affective disorders and Multiple Sclerosis.
Key-words
neuroimmunology multiple sclerosisSommario
Gli autori riferiscono sulle ultime interpretazioni immunologiche riguardanti la patogenesi della sclerosi multipla. Vengono presentati i dati concernenti un nouvo metodo immunoenzimatico per l'identificazione delle popolazioni linfocitarie.
Preview
Unable to display preview. Download preview PDF.
References
- [1]Weiner H.L., Hanser S.L.:Neuroimmunology I; immunoregulation in neurological diseases. Ann. Neurol. 11, 437, 1982.CrossRefPubMedGoogle Scholar
- [2]Witaker J.N., Lisak R.P., Bashir R.M., Fitch O.H., Seyer J.M., Krance R., Lawrence J.A., Ch'ieh L.T., O'Sullivan P.:Immunoreactive myelin basic protein in the cerebral spinal fluid in neurological disorders. Ann. Neurol. 7, 58, 1980CrossRefPubMedGoogle Scholar
- [3]Waksman B.H.:Current trends in M. S. research Immunology Today 2, 87, 1981CrossRefGoogle Scholar
- [4]Caputo D.,Ferrante P.Indagini virologiche nella S.M. Atti XXII Congresso Naz. SIN — Scalea 5–7/XI, 1981 Crippa e Berger Ed. pag. 189.Google Scholar
- [5]Ferrante P.:Il ruolo degli Studi virologici nella comprensione della eziologia della S.M. Proposte Atti HI Convegno di Neuroepidemiologia — Milano 1982.Google Scholar
- [6]Bergamini F.:Slow virus e malattie croniche del SNC. Boll. Ist. Sieroter. Milano. 56, 589–596, 1977Google Scholar
- [7]Choppin P.W., Richardson C.D., Merz D.C., Hall W.W., Sheid A.:The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in SSPE. J. Infect. Dis. 143, 352, 1981.PubMedGoogle Scholar
- [8]Martin J.R.,Herpes simplex virus type 1 and 2 and M.S. Lancet ii, 777, 1981.CrossRefGoogle Scholar
- [9]Warner H.B., Carp R.I.:M.S. and Epstein-Barr virus. Lancet ii, 1290, 1981CrossRefGoogle Scholar
- [10]Delmotte P.:Resultats comparatifs de l'électrophorèse en agar et de l'examen par électrofocalization des gammaglobulines du liquide céphalorachidien. Acta Neurol. Belg. 72, 226, 1972.PubMedGoogle Scholar
- [11]Delmotte P., Gonsette R.:Biochemical findings in M.S. IV Isoelectric focusing of the CSF gammaglobulins in M.S. and OND. J. Neurol. 216, 27, 1977.CrossRefPubMedGoogle Scholar
- [12]Kyellin K.G., Vestenberg O.:Isoelectric focusing of CSF in neurological diseases. J. Neurol. Sci. 23, 199, 1974.CrossRefPubMedGoogle Scholar
- [13]Procaccia S., Nickerson C.J., Caputo D., Cazzullo C.L., Zanussi C.:Cerebrospinal fluid immunoglobulins G in patients with M.S. The Menarin Series on Immunopathology II Symp. Milan June 14–16 1978. Eds Schwabe e Co. LTD - Basel 77, 231, 1979Google Scholar
- [14]Vandvik B., Degre M.:Measles virus antibodies in serum and cerebrospinal fluid in patients with M.S. and other neurological disorders with special reference to measles antibody synthesis within the central nervous system. J. Neurol. Sci. 24, 201, 1975CrossRefPubMedGoogle Scholar
- [15]
- [16]Procaccia S. Caputo D., Ferrante P. et al. Circulating and viral antibodies in MS.New Trends in M.S. research Ed. by Cazzullo C.L., Caputo D., Ghezzi A., Masson (MI), 1983 (in Press)Google Scholar
- [17]Over J.F., Arnason B.G.W., Wray S.M., Wistler J.P.:A study of bands T cells in M.S. Neurology 25, 444, 1975PubMedGoogle Scholar
- [18]Antel J.P., Richman D.P., Medof M.E., Arnason B.G.W.:Lymphocyte function and the role of regulator cells in M.S. Neurology 28, Suppl. 106, 1978PubMedGoogle Scholar
- [19]Bach M.A., Phan-Dinh-Tuy F., Tonnier S., Chatenoud L., Bach J.F., Martin C., Deges J.D.:Deficit of Suppressor T cells in active M.S. Lancet ii, 1221, 1980CrossRefGoogle Scholar
- [20]Huddlestone J.R., Oldstone M.B.A.:T suppressor lymphocytes fluctuate in parallel with changes in the clinical cause of patients with M.S.I. J. Immunol. 123, 1615, 1979PubMedGoogle Scholar
- [21]Reinhertz E.L., Weiner H.L., Hansen S.L., Cochen J.A., Distaso J.A., Schlossman S.F.:Loss of suppressor T cells in active M.S. N. Engl. J. Med. 3, 125, 1980.Google Scholar
- [22]Bloom B.R.:Immunological changes in M.S. Nature 287, 275, 1980CrossRefPubMedGoogle Scholar
- [23]Merrill J.E., Biberfled G., Landia S. Siden A., Norrby E.:Identification of three FcR-positive T cell subsets (T, T mu and T gamma mu) in the CSF of M.S. patients. Clin. Exp. Immunol. 42 (2) 345, 1980PubMedGoogle Scholar
- [24]Ortiz-Ortiz G., Nakamura F., Weigle A.:T-cell requirement for Experimental Allergic Encephalomyelitis induction in the rat. J. Immunol. 117, 575–579, 1976Google Scholar
- [25]Whitacre C.C., Paterson P.Y.:Experimental Allergic Encephalomyelitis supernatant transfer activity in Lewis Rats: immunobiologic and initial biochemical properties J. Immunol. 124, 1784–1787, 1980PubMedGoogle Scholar
- [26]Whitacre C.C., Paterson P.Y., Day A.D., Bornstein M.B.:Experimental Allergic Encephalomyelitis Supernate Transfer Activity in Lewis Rats: undiminished activity of Ig-depleted supernates and evidence for xenogeneic restriction. Cell. Immunol. 52, 78–84, 1981.Google Scholar
- [27]Traugott U., Raine C.S.:Experimental Allergic Encephalomyelitis in inbred guinea pigs: correlation of decrease in early-T-cells with clinical signs in suppressed and unsuppressed animals. Cell. Immunol. 34, 146–155, 1977CrossRefPubMedGoogle Scholar
- [28]Traugott U., Stone S.H., Raine C.S.:Chronic relapsing experimental allergic encephalomyelitis. Correlation of lymphocytes circulating fluctuations with disease activity in suppressed and unsuppressed animals. J. Neurol. Sci. 41, 17–19, 1979CrossRefPubMedGoogle Scholar
- [29]Catovsky D.:T-cell origin of acid-phopshatasepositive lymphoblasts. Lancet 2, 327–328, 1975.CrossRefPubMedGoogle Scholar
- [30]Catovky D., Enno A.:Morphological and cytochemical identification of lymphoid cell. Lymphology 10, 77–84, 1977.PubMedGoogle Scholar
- [31]Li C.Y., Lam K.W., Yam L.T.:Esterase in human leukocytes. J. Histochem. Cytochem. 21, 12, 1973.Google Scholar
- [32]Tamaoky N., Essner E.:Distribution of acid phosphatase, beta-glucuronidase and N-acetylbeta-glucosaminidase activities in lymphocytes of lymphatic tissues of man and rodents. J. Histochem. Cytochem. 17, 238–243, 1969.PubMedGoogle Scholar
- [33]Knowles D.M., Holck S.:Tissue localization of T-lymphocytes by the histochemical demonstration of acid alpha-acetate esterase. Lab. Inv. 39, 70–76, 1978Google Scholar
- [34]Knowles D.M., Halper J.P., Machin G.A., Sherman W.:Acid alpha-naphthyl-acetate esterase activity in human neoplastic lymphoid cells: usefulness as a T-cell marker. Am. J. Pathol. 96, 257–278, 1979.PubMedGoogle Scholar
- [35]Pinkus G.S., Hargreaves H.M., McLedd J.A., Nadler M.L., Rosenthal D.S., Said J.W.:Alpha-naphthyl acetate esterase activity: a cytochemical marker for T-lymphocytes. Am. Ass. of Pathologist 97, 18–41, 1979.Google Scholar
- [36]Pangalis G.A., Waldman S.R., Rappaport H.:Cytochemical findings in human non neoplastic blood and tonsillar B and T lymphocytes. Am. J. Clin. Pathol. 69, 314–318, 1978.PubMedGoogle Scholar
- [37]Yang K., Bearman R.M., Gerassimos A., Pangalis, Zelman R.J., Rappaport H.:Acid phosphatase and alpha-naphthyl acetate esterase in neoplastic and non-neoplastic lymhocytes. Am. J. Clin. Pathol. 78, 141–149, 1982.PubMedGoogle Scholar
- [38]Grossi C.E., Webb S.R., Zicca A., Lydyard P.M., Moretta L., Mingari M., Copper M.D.:Morphological and histochemical analyses of two human T-Cell sub-populations bearing receptors for IgM or IgG. J. Exp. Med. 147, 1405–1417, 1978.CrossRefPubMedGoogle Scholar
- [39]Manconi P.E., Maposu M.G., Paghi L., Correale G., Zaccheo D.:Alpha-napthyl acetateesterase activity in human lymphocytes distribution in lymphocyte subpopulations and in mitogenactivated cells. Scand. J. Immunol. 9, 99–104, 1979.PubMedGoogle Scholar
- [40]Bouet J.C., Valensi F., Daniel M.T., Flandrin G., Preud'homme J.L., Seligmann M.:Immunological classification of ALL: evaluation of its clinical significance in a hundred patients. Br. J. Haematol. 33, 319–328, 1976.PubMedGoogle Scholar
- [41]Ranky A.:Non specific esterase activity in human lymphocytes: histochemical characterization and demonstration among major lymphocytes subclasses. Clin. Immun. Immunopathol. 10, 47–58, 1978.CrossRefGoogle Scholar
- [42]Cazzullo C.L., Smeraldi E.:HL-A antigens and multiple sclerosis. Lancet ii, 429, 1972.CrossRefGoogle Scholar
- [43]Zibetti A., Cazzullo C.L., Smeraldi E., Scor-za-Smeraldi R.:HLA typing on Italian M.S. population. Boll. Ist. Sieroter. Milan. 56, 6, 583, 1977.Google Scholar
- [44]Coming D.E.:PC1 Duarte a common polymorphism of a human brain protein and its relationship to depressive disease and M.S.. Nature 277, 28, 1979.CrossRefPubMedGoogle Scholar
- [45]Cazzullo C.L.,Smeraldi E.,Gasparini M.,Caputo D.:Preliminary correlation between primary affective disorders and multiple sclerosis. New Trends in M.S. research. Edited by Cazzullo C.L., Caputo D., Ghezzi A. - Masson Italia (MI) — In Press.Google Scholar
- [46]Gasser D.L., Newlin C.M., Palm J., Gonatas N.K.:Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181, 872, 1973.PubMedGoogle Scholar
Copyright information
© Masson Italia Editori S.p.A. 1983